Pycnogenol (French Maritime Pine Bark) for the Treatment of Gulf War Illness

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorUniversity of Alabama at Birmingham

About this trial

The purpose of this research study is to determine how pycnogenol may reduce Gulf War Illness (GWI) symptom severity. The study will also examine the safety of this treatment and determine the optimal dosage. The investigators believe that GWI involves inflammation in the body and brain that causes fatigue, pain, cognitive disruption, and other symptoms. Botanicals that reduce inflammation may help treat GWI.

Eligibility criteria

Qualifiers

Meet the Kansas GWI case definition

Meet the CDC GWI case definition

Able to commit to a 12-month study

Male

Disqualifiers

Currently involved in another experimental treatment study

Female

Have a blood clotting disorder

Reported diagnosis of diabetes with a A1C greater than 9

Trial design

Treatments tested in this trial

  • Placebo
  • Pycnogenol, 100mg
  • Pycnogenol, 200mg
  • Pycnogenol, 400mg
  • Pycnogenol, 600mg

Treatment groups

20 Participants
are divided into 1 treatment group